News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Oxford BioTherapeutics Appoints Bryan G. Morton as Chairman


6/26/2013 6:26:13 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

OXFORD, England, June 26, 2013 /PRNewswire/ --

Oxford BioTherapeutics (OBT), a global biotechnology company developing first-in-class, antibody-based cancer medicines to fulfil unmet patient needs, today announces the appointment of Bryan G. Morton as the Company's new Non-executive Chairman.

Help employers find you! Check out all the jobs and post your resume.

Read at Yahoo Finance

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES